Home・Elenco Azioni・Erasca Inc

Erasca Inc

Chiusa

18.1 -0.55

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

17.8

Massimo

18.69

Metriche Chiave
By Trading Economics
Entrata	-154M -183M
EPS	-0.6
Dipendenti	103
EBITDA	-151M -183M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+25.05% upside

Dividendi
By Acuity
Utili prossimi	10 nov 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	3B 6.3B
Apertura precedente	18.65
Chiusura precedente	18.1

Erasca Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

18 ago 2026, 23:56 UTC

Correlated Moves

Hecla Mining Co shares are lower in after-market trading, pressured by declining silver prices and rising sovereign bond yields amid inflation concerns.

18 ago 2026, 23:56 UTC

Huntington Ingalls Industries shares are higher in after-market trading, reflecting strength above its 20-day moving average and near the upper end of its one-month range.

18 ago 2026, 23:56 UTC

News

Exelixis shares are lower in after-market hours following BMO's Market Perform rating. Broader market pressures from rising bond yields also weigh on the stock.

18 ago 2026, 23:56 UTC

American Water Works shares are higher in after-market trading, despite rising sovereign bond yields impacting investor sentiment across equities.

18 ago 2026, 23:56 UTC

Coursera Inc shares are higher in after-market trading, despite no specific news driving the movement. Broader market conditions reflect rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Correlated Moves

Social Media

The iShares Core U.S. Aggregate Bond ETF rose slightly in after-market trading, reflecting recent fluctuations in the 10-year yield and broader market sentiment.

18 ago 2026, 23:56 UTC

Steel Dynamics Inc shares are trading lower in after-market hours, remaining below the 20-day moving average amid ongoing market weakness. No specific news was identified.

18 ago 2026, 23:56 UTC

Chipotle Mexican Grill Inc shares are higher in after-market trading, reflecting a modest increase since Tuesday's close amid rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Array Technologies Inc shares are higher in after-market trading, reflecting a modest gain since Tuesday's close. The stock remains below its 20-day moving average.

18 ago 2026, 23:56 UTC

News

Carvana Co's shares are higher in after-market trading amid concerns over major shareholder Mark Walter's federal investigation and potential stake sale valued at $2 billion.

18 ago 2026, 23:56 UTC

Correlated Moves

Vicor Corp shares are lower in after-hours trading amid broader market volatility and concerns over rising bond yields and geopolitical tensions.

18 ago 2026, 23:56 UTC

VF Corp shares are higher in after-market trading following a recovery from an earlier decline. The price remains below its 20-day moving average.

18 ago 2026, 23:56 UTC

Fastenal Co shares are higher in after-market trading, maintaining performance above the 20-day moving average despite concerns over rising sovereign bond yields.

18 ago 2026, 23:56 UTC

Paccar Inc shares rose in after-market trading, despite no specific news. The stock remains below its 20-day moving average amid broader market pressures.

18 ago 2026, 23:56 UTC

Correlated Moves

Morgan Stanley shares are lower in after-market trading amid unusual volatility and rising bond yields, which are pressuring equities and growth prospects.

18 ago 2026, 23:56 UTC

Social Media

Johnson & Johnson returns the C-CAR039 program to AbelZeta, while discussions about a potential acquisition of Legend Biotech continue. Shares are roughly flat in after-market trading.

18 ago 2026, 23:56 UTC

Correlated Moves

Campbell Soup Co shares are higher in after-market trading, advancing since Tuesday's close and positioning above the 20-day moving average.

18 ago 2026, 23:56 UTC

Upbound Group Inc shares are higher in after-market hours, recovering from three consecutive lower closes, though still below the 20-day moving average.

18 ago 2026, 23:56 UTC

CEVA Inc. shares gained in after-market trading, reaching a high above Tuesday's close, though they remain below their 20-day moving average.

18 ago 2026, 23:56 UTC

Coca-Cola Co's shares are higher in after-market trading, reflecting a modest increase since Tuesday's close. The stock remains above its 20-day moving average.

18 ago 2026, 23:52 UTC

News

Social Media

IONQ partners with CMC Microsystems to enhance cloud quantum computing access in Canada. Shares are lower in after-market hours following the announcement.

18 ago 2026, 23:51 UTC

Agilent Technologies Inc shares declined in after-market hours amid broader market concerns over rising bond yields and inflation linked to geopolitical tensions.

18 ago 2026, 23:51 UTC

Genpact Ltd shares are lower in after-market hours amid concerns over elevated bond yields and inflation, despite initial gains earlier in the session.

18 ago 2026, 23:51 UTC

Northrop Grumman shares are higher in after-market hours, remaining above their 20-day moving average and near the upper end of their one-month range.

18 ago 2026, 23:51 UTC

Correlated Moves

Lennox International Inc shares are higher in after-market trading, reflecting broader trends in correlated assets like Toll Brothers Inc amid rising bond yields.

18 ago 2026, 23:51 UTC

Correlated Moves

Pultegroup Inc shares are lower in after-market hours, following declines in the Russell 2000 Index and rising concerns over elevated bond yields.

18 ago 2026, 23:51 UTC

Correlated Moves

Ichor Holdings Ltd shares are lower in after-market hours, influenced by a decline in the Nasdaq 100 Index and rising bond yields.

18 ago 2026, 23:51 UTC

Monday.Com Ltd. shares declined after-market amid concerns over rising bond yields and inflation. The stock remains above its 20-day moving average.

18 ago 2026, 23:51 UTC

Cardinal Health Inc. shares are lower in after-market trading, maintaining declines amid broader market concerns over elevated bond yields and inflation linked to geopolitical tensions.

18 ago 2026, 23:51 UTC

Correlated Moves

Lam Research shares declined in after-market trading, influenced by rising bond yields and broader market trends, including a slight drop in the Nasdaq 100 Index.

Confronto tra pari

Modifica del prezzo

Erasca Inc Previsione

Obiettivo di Prezzo

By TipRanks

25.05% in crescita

Previsioni per 12 mesi

Media 22.86 USD 25.05%

Alto 30 USD

Basso 20 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Erasca Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

7 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 7 che hanno fornito valutazioni azionarie a Erasca Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.